Research Paper Volume 12, Issue 3 pp 2132—2141

EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients

class="figure-viewer-img"

Figure 1. Landscapes of frequently mutated genes in bladder cancer. (A) Oncoplot depicts the frequently mutated genes in bladder cancer from TCGA cohort. The left panel shows mutation frequency, and genes are ordered by their mutation frequencies. The bottom panel presents different mutation types. (B) Waterfall plot displays the frequently mutated genes in bladder cancer from ICGC cohort. The left panel shows the genes ordered by their mutation frequencies. The right panel presents different mutation types. (C) Venn diagram of frequently mutated genes covered by both TCGA and ICGC cohorts.